Variant report
Variant | esv2036663 |
---|---|
Chromosome Location | chr12:29995702-29996107 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:29995160..29997764-chr12:29998716..30001221,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs60515177 | chr12:29995718-29995719 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs114119130 | chr12:29995725-29995726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114773689 | chr12:29995732-29995733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74649207 | chr12:29995734-29995735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114142768 | chr12:29995746-29995747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565900405 | chr12:29995752-29995753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544214323 | chr12:29995759-29995760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77313606 | chr12:29995760-29995761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536424966 | chr12:29995772-29995773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190203791 | chr12:29995780-29995781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79601502 | chr12:29995862-29995863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386761571 | chr12:29995872-29995873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115285615 | chr12:29995873-29995874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139277977 | chr12:29995884-29995885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376919285 | chr12:29995887-29995888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201417124 | chr12:29995892-29995893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs55644412 | chr12:29995894-29995895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79046102 | chr12:29995902-29995903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373434079 | chr12:29995910-29995911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148445844 | chr12:29995914-29995915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568955612 | chr12:29995955-29995956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139012164 | chr12:29995968-29995969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182479712 | chr12:29996024-29996025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74080032 | chr12:29996070-29996071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533958933 | chr12:29996075-29996076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12315716 | chr12:29996095-29996096 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:29991600-29997600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:29994000-29996600 | Enhancers | Fetal Brain Male | brain |
3 | chr12:29995000-29998000 | Enhancers | Fetal Lung | lung |
4 | chr12:29996000-29996200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |